Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis
Koji Kinoshita(Kindai University Hospital), Kazuo Ikeda(Yamagata University), Jiro Fujimoto(Harvard University), Yuji Nakajima(Osaka City University), Norifumi Kawada(The University of Osaka), Hiroshi Kiyama(Shijonawate Gakuen University), Scott L. Friedman(Icahn School of Medicine at Mount Sinai), Kohji Otogawa(Osaka City University), Yuji Iimuro(Yamanashi Prefectural Central Hospital), Kazuhiko Namikawa(Osaka City University), Yutaka Inagaki(Tokai University)
Cited by 23
Related Papers
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
|Journal of Biological Chemistry|2000|2.1k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
|The Journal of Experimental Medicine|1998|897
Genome‐wide molecular profiles of HCV‐induced dysplasia and hepatocellular carcinoma†
|Hepatology|2007|755
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
|Gastroenterology|2008|729